Molecular biology and genetics affecting pediatric solid tumors.

Area of Science:

• Molecular Biology
• Cancer Genetics
• Pediatric Oncology

Background:

• Cancer develops due to multiple genetic alterations, including oncogene activation and tumor suppressor gene inactivation.
• These alterations manifest as chromosomal translocations, deletions, inversions, amplifications, or point mutations.
• Understanding these genetic underpinnings is fundamental to comprehending neoplasia development.

Purpose of the Study:

• To review basic molecular biology concepts.
• To describe the molecular genetics and clinical findings of key pediatric solid tumors: neuroblastoma, Wilms tumor, and rhabdomyosarcoma.
• To emphasize the importance of molecular genetics for oncology surgeons in multidisciplinary care.

Main Methods:

• Review of existing literature on molecular biology and cancer genetics.
• Synthesis of information on genetic alterations in neuroblastoma, Wilms tumor, and rhabdomyosarcoma.
• Discussion of clinical implications and therapeutic targets.

Main Results:

• Genetic alterations are central to cancer development and progression.
• Specific molecular profiles characterize pediatric solid tumors.
• Fusion proteins from translocations represent tumor-specific antigens and potential therapeutic targets.

Conclusions:

• Oncology surgeons require basic molecular genetics knowledge for effective patient care.
• Identification of oncogenes and tumor-specific antigens are vital for diagnosis, recurrence detection, and gene therapy.
• Future technological advancements in molecular genetics will enable targeted cancer therapies, including manipulation of nuclear DNA.